Literature DB >> 8789020

Axenic growth and drug sensitivity studies of Balamuthia mandrillaris, an agent of amebic meningoencephalitis in humans and other animals.

F L Schuster1, G S Visvesvara.   

Abstract

A cell-free growth medium for the opportunistic pathogenic ameba Balamuthia mandrillaris is presented. This represents an advance over the use of monkey kidney cells for growth of the amebas and can be helpful in isolation of these amebas from brain tissue from cases in which amebic meningoencephalitis is a diagnostic possibility, as well as for biochemical and molecular biological studies. Three isolates of Balamuthia have been cultured in this medium. The cell-free growth system was also used to screen cultures for sensitivity to a variety of antimicrobial agents. Of the various drugs tested, pentamidine isethionate was most effective against amebas (ca. 90% inhibition after 6 days of exposure), but the drug was amebastatic and not amebacidal in the axenic system at the highest concentration tested (10 micrograms/ml).

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8789020      PMCID: PMC228802          DOI: 10.1128/jcm.34.2.385-388.1996

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  9 in total

1.  Granulomatous amoebic encephalitis due to leptomyxid amoebae: report of the first Brazilian case.

Authors:  L Chimelli; M D Hahn; F Scaravilli; S Wallace; G S Visvesvara
Journal:  Trans R Soc Trop Med Hyg       Date:  1992 Nov-Dec       Impact factor: 2.184

2.  Leptomyxid amoeba encephalitis: report of the first case in Argentina.

Authors:  A L Taratuto; J Monges; J C Acefe; F Meli; A Paredes; A J Martinez
Journal:  Trans R Soc Trop Med Hyg       Date:  1991 Jan-Feb       Impact factor: 2.184

3.  Balamuthia mandrillaris, N. G., N. Sp., agent of amebic meningoencephalitis in humans and other animals.

Authors:  G S Visvesvara; F L Schuster; A J Martinez
Journal:  J Eukaryot Microbiol       Date:  1993 Jul-Aug       Impact factor: 3.346

Review 4.  Leptomyxid ameba, a new agent of amebic meningoencephalitis in humans and animals.

Authors:  G S Visvesvara; A J Martinez; F L Schuster; G J Leitch; S V Wallace; T K Sawyer; M Anderson
Journal:  J Clin Microbiol       Date:  1990-12       Impact factor: 5.948

Review 5.  Unusual infections in humans.

Authors:  R C Neafie; A M Marty
Journal:  Clin Microbiol Rev       Date:  1993-01       Impact factor: 26.132

Review 6.  Culture isolation of Acanthamoeba species and leptomyxid amebas from patients with amebic meningoencephalitis, including two patients with AIDS.

Authors:  S M Gordon; J P Steinberg; M H DuPuis; P E Kozarsky; J F Nickerson; G S Visvesvara
Journal:  Clin Infect Dis       Date:  1992-12       Impact factor: 9.079

7.  Amebic meningoencephalitis in a patient with AIDS caused by a newly recognized opportunistic pathogen. Leptomyxid ameba.

Authors:  A P Anzil; C Rao; M A Wrzolek; G S Visvesvara; J H Sher; P B Kozlowski
Journal:  Arch Pathol Lab Med       Date:  1991-01       Impact factor: 5.534

8.  Granulomatous amebic encephalitis: a review and report of a spontaneous case from Venezuela.

Authors:  A J Martínez; A E Guerra; J García-Tamayo; G Céspedes; J E González-Alfonzo; G S Visvesvara
Journal:  Acta Neuropathol       Date:  1994       Impact factor: 17.088

Review 9.  Amebic meningoencephalitis caused by Balamuthia mandrillaris.

Authors:  D A Griesemer; L L Barton; C M Reese; P C Johnson; J A Gabrielsen; D Talwar; G S Visvesvara
Journal:  Pediatr Neurol       Date:  1994-05       Impact factor: 3.372

  9 in total
  33 in total

1.  Balamuthia mandrillaris amoebic encephalitis: an emerging parasitic infection.

Authors:  Francisco G Bravo; Carlos Seas
Journal:  Curr Infect Dis Rep       Date:  2012-08       Impact factor: 3.725

2.  Oral infection of immunocompetent and immunodeficient mice with Balamuthia mandrillaris amebae.

Authors:  Albrecht F Kiderlen; Ulrike Laube; Elke Radam; Phiroze S Tata
Journal:  Parasitol Res       Date:  2006-11-17       Impact factor: 2.289

3.  Effect of antimicrobial compounds on Balamuthia mandrillaris encystment and human brain microvascular endothelial cell cytopathogenicity.

Authors:  Ruqaiyyah Siddiqui; Abdul Matin; David Warhurst; Monique Stins; Naveed Ahmed Khan
Journal:  Antimicrob Agents Chemother       Date:  2007-09-17       Impact factor: 5.191

4.  Detection of Balamuthia mitochondrial 16S rRNA gene DNA in clinical specimens by PCR.

Authors:  Shigeo Yagi; Gregory C Booton; Govinda S Visvesvara; Frederick L Schuster
Journal:  J Clin Microbiol       Date:  2005-07       Impact factor: 5.948

Review 5.  The Ecology and Evolution of Amoeba-Bacterium Interactions.

Authors:  Yijing Shi; David C Queller; Yuehui Tian; Siyi Zhang; Qingyun Yan; Zhili He; Zhenzhen He; Chenyuan Wu; Cheng Wang; Longfei Shu
Journal:  Appl Environ Microbiol       Date:  2021-01-04       Impact factor: 4.792

6.  Balamuthia mandrillaris, an opportunistic agent of granulomatous amebic encephalitis, infects the brain via the olfactory nerve pathway.

Authors:  Albrecht F Kiderlen; Ulrike Laube
Journal:  Parasitol Res       Date:  2004-07-30       Impact factor: 2.289

7.  Environmental isolation of Balamuthia mandrillaris associated with a case of amebic encephalitis.

Authors:  Frederick L Schuster; Thelma H Dunnebacke; Gregory C Booton; Shigeo Yagi; Candice K Kohlmeier; Carol Glaser; Duc Vugia; Anna Bakardjiev; Parvin Azimi; Mary Maddux-Gonzalez; A Julio Martinez; Govinda S Visvesvara
Journal:  J Clin Microbiol       Date:  2003-07       Impact factor: 5.948

8.  Inhibition of monkeypox virus replication by RNA interference.

Authors:  Abdulnaser Alkhalil; Sarah Strand; Eric Mucker; John W Huggins; Peter B Jahrling; Sofi M Ibrahim
Journal:  Virol J       Date:  2009-11-04       Impact factor: 4.099

9.  Gene expression profiling of monkeypox virus-infected cells reveals novel interfaces for host-virus interactions.

Authors:  Abdulnaser Alkhalil; Rasha Hammamieh; Justin Hardick; Mohamed Ait Ichou; Marti Jett; Sofi Ibrahim
Journal:  Virol J       Date:  2010-07-28       Impact factor: 4.099

10.  Assessment of blood-brain barrier penetration of miltefosine used to treat a fatal case of granulomatous amebic encephalitis possibly caused by an unusual Balamuthia mandrillaris strain.

Authors:  Sharon L Roy; Jane T Atkins; Rosemaria Gennuso; Danny Kofos; Rama R Sriram; Thomas P C Dorlo; Teresa Hayes; Yvonne Qvarnstrom; Zuzana Kucerova; B Joseph Guglielmo; Govinda S Visvesvara
Journal:  Parasitol Res       Date:  2015-09-02       Impact factor: 2.289

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.